The Lancet: Patients with complications after major surgery more likely to survive if readmitted to the same hospital
2015-06-18
(Press-News.org) Patients rehospitalized with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation compared to those readmitted to a different hospital, according to a national study involving over 9 million Medicare patients in the USA, published in The Lancet.
The findings stand in contrast to current health policies that aim to regionalise major surgical procedures into high volume centres of excellence.
"With up to one in four patients rehospitalized following complex surgery, our results could potentially translate into thousands of lives saved every year in the USA alone if patients returned to the hospital where they had the procedure and received care from their original surgical team" [1], explains lead author Dr Benjamin Brooke from the University of Utah School of Medicine in Salt Lake City, USA.
Brooke and colleagues examined data from more than 9 million (9440503) Medicare beneficiaries in the USA between January, 2001 and November, 2011, who underwent 12 common high-risk operations [2]. They used different statistical models to investigate the association between readmission destination (ie, the index hospital where the procedure took place vs a different hospital) and risk of death within 90 days of the procedure. This included instrumental variable analyses to account for potential unmeasured bias. This approach effectively allows researchers to simulate randomisation of patients who were readmitted following surgery and to generate unbiased estimates.
The number of patients rehospitalised with complications within 30 days of their operation ranged from 5.6% (154203 patients) of knee replacement patients, to 22% (3665) of oesophagectomy (surgical removal of all or part of the oesophagus) patients. Of patients rehospitalized, those readmitted to the same hospital ranged from two-thirds (186336) after coronary artery bypass grafting, to 83% (142142) following colectomy (surgical removal of all or part of the colon).
The researchers found that patients readmitted to the same hospital were 26% less likely to die within 90 days than those readmitted to a different hospital, even after taking into account measures of surgical quality that can affect mortality such as hospital size, teaching status, and volume of procedures. When confounding was controlled with instrumental variable analysis, patients returning to the index hospital were 8% less likely to die than those returning to a different hospital.
According to Dr Brooke, "Patients increasingly travel long distances to have their operations done at hospitals that are recognised as providing high-quality care or because of lower costs for health insurers. The assumption has been that if patients need readmission for complications they can seek care at local hospitals without compromising outcomes. However, our findings suggest that maintaining continuity of care when readmissions occur is a more important predictor of survival than other established surgical quality measures such as hospital procedure volume and needs to be considered in the trade-offs when choosing a hospital for surgery." [1]
Dr Justin Dimick and Dr David Miller from the University of Michigan, Ann Arbor, Michigan, USA, authors of a linked Comment, say, "After many years of evidence supporting the advantages of regionalizing complex surgery, Brooke and colleagues provide the first definitive empirical evidence that travelling to a remote hospital for surgery may be potentially life threatening. These findings have important implications for existing selective referral and centre of excellence programmes. If patients need to travel long distances to receive care, every effort should be made to ensure that the post-surgical patient is readmitted to the hospital where they had surgery." [1]
INFORMATION:
NOTES TO EDITORS:
[1] Quotes direct from authors and cannot be found in text of Article / Comment.
[2] Open abdominal aortic aneurysm repair, infrainguinal arterial bypass, aortobifemoral bypass, coronary artery bypass surgery, oesophagectomy (surgical removal of all or part of the oesophagus), colectomy (surgical removal of all or part of the colon), pancreatectomy (surgery to remove all or part of the pancreas), cholecystectomy (surgical removal of the gallbladder), ventral hernia repair, craniotomy, hip replacement, or knee replacement.
ELSE PRESS RELEASES FROM THIS DATE:
2015-06-18
In The BMJ this week, two doctors criticize Australia for passing legislation that may be used to silence doctors working with asylum seekers.
The Border Force Act 2015 says that from July 2015 contracted workers including doctors, nurses, and other healthcare professionals face a prison sentence of up to two years for blowing the whistle on substandard medical care given to asylum seekers in detention centres.
Dr. David Berger at Broome Hospital in Western Australia, argues that the only reason to suppress doctors in this way, 'is to avoid embarrassing revelations ...
2015-06-18
Two Massachusetts General Hospital (MGH) physicians who participated in the international response to the major earthquakes that hit Nepal in April and May each describe their experiences in Perspectives articles receiving Online First publication today in the New England Journal of Medicine.
Renee Salas, MD, MS, was already in Nepal working at a Himalayan Rescue Association clinic in the remote village of Pheriche when the first 7.8 magnitude quake struck on April 25. As she describes in her article "Humanity, Teamwork and Art in Post-Earthquake Nepal," while the immediate ...
2015-06-18
WHAT:
Researchers funded by the National Institutes of Health (NIH) have identified a new immune disorder--DOCK2 deficiency--named after the mutated gene responsible for the disease. An international team of collaborators studied five children, four boys and one girl, from different ethnic backgrounds who had experienced debilitating infections early in life. The children were diagnosed with combined immunodeficiency (CID), which refers to a group of inherited disorders distinguished by defects in immune system cells called T cells. CIDs also may affect other cells of ...
2015-06-17
WASHINGTON, June 17 --- The value of the tax exemption provided to non-profit private hospitals in return for 'charity care and community benefit' nearly doubled over a nine-year period, climbing from an estimated $12.6 billion in 2002 to $24.6 billion dollars by 2011, according to a study funded by the Robert Wood Johnson Foundation and led by researchers at Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University.
This growth in the value of the tax exemption underscores taxpayer interest in how hospitals allocate their community ...
2015-06-17
MAYWOOD, Ill. - A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
There are no effective drugs to prevent or reverse NF. But increasing scientific knowledge has allowed for better clinical management and fewer complications, resulting in a higher quality of life for neurofibromatosis patients, NF specialists report in the Journal of Neuropsychiatry and Clinical Neurosciences.
Pediatric neurologist and NF specialist Nikolas Mata-Machado, MD, of Loyola University Medical Center, ...
2015-06-17
Like homing pigeons, humans have a nose for navigation because our brains are wired to convert smells into spatial information, new research from the University of California, Berkeley, shows.
While humans may lack the scent-tracking sophistication of, say, a search-and-rescue dog, we can sniff our way, blindfolded, toward a location whose scent we've smelled only once before, according to the UC Berkeley study published today (June 17) in the journal PLOS ONE.
Similar investigations have been conducted on birds and rodents, but this is the first time smell-based navigation ...
2015-06-17
(New York, June 17, 2015) Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.
The research team found that the protein, called H2A.Z.2, promotes the abnormal growth seen in melanoma cells as they develop into difficult-to-treat tumors. H2A.Z.2 is part of the chromosome structure that packages genes, and has the ability to switch them on off. Having high levels of ...
2015-06-17
Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis.
The study, which compared 7,783 men with prostate cancer to 38,595 men without the disease, is available online and will be published in an upcoming issue of the journal Cancer Discovery.
The new study is one of the first to come out of the collaboration between UCSF and Kaiser Permanente ...
2015-06-17
A typical computer chip includes millions of transistors connected with an extensive network of copper wires. Although chip wires are unimaginably short and thin compared to household wires both have one thing in common: in each case the copper is wrapped within a protective sheath.
For years a material called tantalum nitride has formed protective layer in chip wires.
Now Stanford-led experiments demonstrate that a different sheathing material, graphene, can help electrons scoot through tiny copper wires in chips more quickly.
Graphene is a single layer of carbon ...
2015-06-17
Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs before they begin treatment, researchers at University of California, San Diego School of Medicine conducted a proof-of-principle study with a small group of metastatic colorectal cancer patients. The results, published June 17 in PLOS ONE, revealed two genes that could help physicians make more informed treatment decisions for patients with this disease.
Metastatic colorectal ...
LAST 30 PRESS RELEASES:
[Press-News.org] The Lancet: Patients with complications after major surgery more likely to survive if readmitted to the same hospital